TIMP1 and non-small cell lung carcinoma: To assess clinical relevance, we explored an independent NSCLC cohort through the AMC OncoGenomics portal (GSE43580), where KRAS and TIMP1 mRNA levels showed an inverse association (Figure 1C) [28].